Dose comparison trial of sustained-release fampridine in multiple sclerosis von GOODMAN, A. D, BROWN, T. R, COHEN, J. A, KRUPP, L. B, SCHAPIRO, R, SCHWID, S. R, COHEN, R, MARINUCCI, L. N, BLIGHT, A. R

Volltext

Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate von Ford, C., Goodman, AD, Johnson, K., Kachuck, N., Lindsey, JW, Lisak, R., Luzzio, C., Myers, L., Panitch, H., Preiningerova, J., Pruitt, A., Rose, J., Rus, H., Wolinsky, J.

Volltext

Rapid disease course in African Americans with multiple sclerosis von KISTER, I, CHAMOT, E, JUBELT, B, KRUPP, L, LENIHAN, M, LUBLIN, F, MIHAI, C, MILLER, A, MUNSCHAUER, F. E, PEREL, A. B, TETER, B. E, WEINSTOCK-GUTTMAN, B, BACON, J. H, ZIVADINOV, R, HERBERT, J, NIEWCZYK, P. M, DE GUZMAN, R. A, APATOFF, B, COYLE, P, GOODMAN, A. D, GOTTESMAN, M, GRANGER, C

Volltext

GLANCE : Results of a phase 2, randomized, double-blind, placebo-controlled study von GOODMAN, A. D, ROSSMAN, H, PANZARA, M. A, SANDROCK, A. W, BAR-OR, A, MILLER, A, MILLER, D. H, SCHMIERER, K, LUBLIN, F, KHAN, O, BORMANN, N. M, YANG, M

Volltext

What Does the Brain Do When You Fake It? An fMRI Study of Pantomimed and Real Grasping von Kroliczak, G, Cavina-Pratesi, C, Goodman, D. A, Culham, J. C

Volltext

Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeks von Morrow, SA, O'Connor, PW, Polman, CH, Goodman, AD, Kappos, L, Lublin, FD, Rudick, RA, Jurgensen, S, Paes, D, Forrestal, F, Benedict, RHB

Volltext

Fampridine-SR in multiple sclerosis: a randomized, double-blind, placebo-controlled, dose-ranging study von Goodman, A.D., Cohen, J.A., Cross, A., Vollmer, T., Rizzo, M., Cohen, R., Marinucci, L., Blight, A.R.

Volltext

Results of the Avonex Combination Trial (ACT) in relapsing-remitting MS von COHEN, J. A, IMREY, P. B, HUTTON, G. J, MANDELL, B. F, SCOTT, T. F, ZHANG, H, APPERSON-HANSEN, C, BECK, G. J, HOUGHTALING, P. L, KARAFA, M. T, STADTLER, M, CALABRESI, P. A, EDWARDS, K. R, EICKENHORST, T, FELTON, W. L, FISHER, E, FOX, R. J, GOODMAN, A. D, HARA-CLEAVER, C

Volltext

United States and territory policies supporting maternal and neonatal transfer: review of transport and reimbursement von Okoroh, E M, Kroelinger, C D, Lasswell, S M, Goodman, D A, Williams, A M, Barfield, W D

Volltext

Expanded prediction equations of human sweat loss and water needs von Gonzalez, R. R, Cheuvront, S. N, Montain, S. J, Goodman, D. A, Blanchard, L. A, Berglund, L. G, Sawka, M. N

Volltext

Quantitative functional measures in MS: What is a reliable change? von SCHWID, S. R, GOODMAN, A. D, MCDERMOTT, M. P, BEVER, C. F, COOK, S. D

Volltext

Randomized, double-blind, dose-comparison study of glatiramer acetate in relapsing-remitting MS von COHEN, J. A, ROVARIS, M, GOODMAN, A. D, LADKANI, D, WYNN, D, FILIPPI, M

Volltext

Quantitative assessment of motor fatigue and strength in MS von SCHWID, S. R, THORNTON, C. A, PANDYA, S, MANZUR, K. L, SANJAK, M, PETRIE, M. D, MCDERMOTT, M. P, GOODMAN, A. D

Volltext

Quantitative assessment of sustained-release 4-aminopyridine for symptomatic treatment of multiple sclerosis von SCHWID, S. R, PETRIE, M. D, MCDERMOTT, M. P, TIERNEY, D. S, MASON, D. H, GOODMAN, A. D

Volltext

Glatiramer acetate (Copaxone): comparison of continuous versus delayed therapy in a six-year organized multiple sclerosis trial von Johnson, K P, Brooks, B R, Ford, C C, Goodman, A D, Lisak, R P, Myers, L W, Pruitt, A A, Rizzo, M A, Rose, J W, Weiner, L P, Wolinsky, J S

Volltext

An open-label safety and drug interaction study of natalizumab (Antegren™) in combination with interferon-beta (Avonex®) in patients with multiple sclerosis von Vollmer, T L, Phillips, J T, Goodman, A D, Agius, M A, Libonati, M A, Giacchino, J L, Grundy, J S

Volltext

Avonex Combination Trial in relapsing—remitting MS: rationale, design and baseline data von Cohen, JA, Calabresi, PA, Chakraborty, S., Edwards, KR, Eickenhorst, T., Felton, WL, Fisher, E., Fox, RJ, Goodman, AD, Hara-Cleaver, C., Hutton, GJ, Imrey, PB, Ivancic, DM, Mandell, BF, Perryman, JE, Scott, TF, Skaramagas, TT, Zhang, H.

Volltext

Benefit of interferon β-1a on MSFC progression in secondary progressive MS von COHEN, J. A, CUTTER, G. R, TSAO, E. C, WHITAKER, J. N, FISCHER, J. S, GOODMAN, A. D, HEIDENREICH, F. R, KOOIJMANS, M. F, SANDROCK, A. W, RUDICK, R. A, SIMON, J. H, SIMONIAN, N. A

Volltext

The measurement of ambulatory impairment in multiple sclerosis von SCHWID, S. R, GOODMAN, A. D, MATTSON, D. H, MIHAI, C, DONOHOE, K. M, PETRIE, M. D, SCHEID, E. A, DUDMAN, J. T, MCDERMOTT, M. P

Volltext

Inpatient surgical treatment of paediatric proximal humerus fractures between 2000 and 2012 von Cruz, A. I., Kleiner, J. E., Gil, J. A., Goodman, A. D., Daniels, A. H., Eberson, C. P.

Volltext